JGP Wealth Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.2M Sell
66,982
-580
-0.9% -$114K 1.27% 19
2026
Q1
$13.2M Sell
67,562
-13,995
-17% -$2.72M 1.38% 18
2025
Q4
$14.2M Sell
81,557
-662
-0.8% -$121K 1.48% 14
2025
Q3
$14.9M Sell
82,219
-183
-0.2% -$32.5K 1.65% 12
2025
Q2
$14.8M Sell
82,402
-615
-0.7% -$107K 1.79% 11
2025
Q1
$14M Sell
83,017
-16,840
-17% -$2.77M 1.85% 12
2024
Q4
$15.1M Buy
99,857
+1,400
+1% +$218K 1.95% 11
2024
Q3
$15.3M Sell
98,457
-701
-0.7% -$105K 1.97% 12
2024
Q2
$13.6M Sell
99,158
-350
-0.4% -$47.9K 1.94% 14
2024
Q1
$13.2M Sell
99,508
-11,640
-10% -$1.51M 1.92% 19
2023
Q4
$15.3M Buy
111,148
+2,892
+3% +$380K 2.28% 12
2023
Q3
$13.2M Buy
108,256
+2,841
+3% +$379K 2.21% 11
2023
Q2
$14.8M Buy
105,415
+3,211
+3% +$443K 2.42% 6
2023
Q1
$14.5M Buy
102,204
+2,647
+3% +$379K 2.54% 5
2022
Q4
$15.6M Buy
99,557
+2,331
+2% +$335K 2.86% 5
2022
Q3
$12M Buy
97,226
+3,055
+3% +$402K 2.52% 7
2022
Q2
$12.8M Buy
94,171
+3,433
+4% +$468K 2.58% 8
2022
Q1
$12.7M Buy
90,738
+4,373
+5% +$610K 2.34% 10
2021
Q4
$13.6M Buy
86,365
+1,976
+2% +$301K 2.53% 8
2021
Q3
$12.3M Sell
84,389
-195
-0.2% -$28.5K 2.65% 6
2021
Q2
$11.2M Buy
84,584
+73,980
+698% +$9.69M 2.4% 8
2021
Q1
$1.36M Buy
10,604
+484
+5% +$59.6K 0.31% 61
2020
Q4
$1.24M Sell
10,120
-26
-0.3% -$3.17K 0.29% 61
2020
Q3
$1.18M Sell
10,146
-422
-4% -$49.9K 0.31% 59
2020
Q2
$1.25M Buy
10,568
+43
+0.4% +$4.56K 0.37% 54
2020
Q1
$925K Buy
+10,525
New +$1.09M 0.33% 67

Other funds holding DGX

JGP Wealth Management's DGX Position: Q2 2026 in Review

JGP Wealth Management reduced its Quest Diagnostics (DGX) stake by 0.86% in Q2 2026, selling an estimated $114K and leaving 66,982 shares worth $14.2M. The position accounts for 1.27% of the portfolio, ranked #19.

JGP Wealth Management first reported a position in DGX in Q1 2020 and has held it in 26 quarters since. The position peaked at $15.6M in Q4 2022. 322 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • JGP Wealth Management held 66,982 shares of Quest Diagnostics worth $14.2M as of Q2 2026.
  • JGP Wealth Management sold 580 Quest Diagnostics shares in Q2 2026, an estimated $114K.
  • Quest Diagnostics made up 1.27% of JGP Wealth Management's portfolio in Q2 2026, its #19 holding.
  • JGP Wealth Management first reported a position in Quest Diagnostics in Q1 2020 and has held it in 26 quarters since.
  • JGP Wealth Management's Quest Diagnostics position peaked at $15.6M in Q4 2022.
  • 322 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on JGP Wealth Management's 13F filing for Q2 2026, filed 7 Jul 2026.